Espinal Tejada, Carlos
- Research Professor, Health Policy and Management , Robert Stempel College of Public Health and Social Work
Overview
overview
-
Dr. Carlos Espinal is the director of the Global Health Consortium and interim chair for the Department of Health Policy & Management at the Robert Stempel College of Public Health & Social Work at Florida International University. He earned his degree in medicine at the University of Antioquia in Medellin, Colombia. He continued his academic career as a fellow at both the New York University School of Medicine and the University of New Mexico School Of Medicine, where he specialized in tropical geographical diseases, epidemiology and malaria vaccine development. Sequentially he also earned a certificate in Public Health and Vaccinology from the Carlos Slim Health Institute in Mexico.
Dr. Espinal’s experience in tropical and geographical diseases, epidemiology and malaria vaccine development includes:
Eight years as a Latin American Regional Adviser in the International Development and Research Center of Canada (IDRC)
Five years as Adviser on the Malaria Sporozoite Vaccine Development Program at the Navy Research Center, Bethesda, Maryland
A PAHO Malaria Adviser on Malaria chemotherapy, drug resistance, and epidemiology.
Fifteen years at the National Institute of Health and Ministry of Health, Colombia, as a Director of Malaria Branch, Tropical Diseases and Epidemiology
Nine years as the Latin American Director of Public Health and Immunization Policy for Sanofi Pasteur based in Washington, DC.
Member and Chairman of the PAHO Jury Committee for the annual selection of the Malaria Champions in Latin America and the Caribbean (2010-2016)
Editor of multiple consensus and guidelines on pediatric, adult vaccination, occupational health and travel medicine in Latin America.
research interests
- Tropical and Geographical Diseases, Epidemiology and Malaria Vaccine; COVID-19
Scholarly & Creative Works
selected publications
-
Article
-
2022Epidemiology of pertussis in Costa Rica and the impact of vaccination: A 58-year experience (1961-2018)Full Text via DOI: 10.1016/j.vaccine.2021.11.078 Web of Science: 000742823100010
-
2021National vaccine coverage trends and funding in Latin America and the CaribbeanFull Text via DOI: 10.1016/j.vaccine.2020.11.059 Web of Science: 000604750300021
-
2020Scientific evidence for the control of antimicrobial resistanceFull Text via DOI: 10.26633/RPSP.2020.155
-
-
Other Scholarly Work
-
2020Scientific evidence for the control of antimicrobial resistanceFull Text via DOI: 10.26633/RPSP.2020.128 Web of Science: 000599514100001
-
-
Review
-
2019Chagas Disease Prevalence in Colombia: A Meta-Analysis and Systematic Review. 81-89.Full Text via DOI: 10.1089/vbz.2018.2308 Web of Science: 000463374600001
-
Research
principal investigator on
- Phase II. Assessment of the impact of the SARSCoV- 2 coronavirus pandemic (Covid-19) in National Immunization Programs in Latin America and the Caribbean awarded by Sanofi 2021 - 2022
- Expanding acP vaccination in Latin America. Sharing experiences with Colombia, Peru and Argentina awarded by Sanofi 2021 - 2022
- The Immunization Task Force of the Americas. A call to action on vaccination and vaccine policy The case of the National Immunization Technical Advisory Groups NITAGs awarded by Sanofi 2021 - 2022
- Building a platform for a proactive and inclusive policy dialogue with the Pan-American Health Organization PAHO, the private sector and other key stakeholders to improve the regional Vaccine Ecosystem based on solid immunization policy guidelines awarded by Fed Latinoamericana Indus Farmaceutica 2021 - 2022
- Pertussis Action Plan 2020 awarded by Sanofi 2020 - 2022
- Assessment of the impact of the SARS-Cov-2 coronavirus pandemic (Covid-19) in National Immunization Programs in Latin America and the Caribbean awarded by Sanofi 2020 - 2021
- Fostering Antimicrobial Resistance in Latin America and the Caribbean "A Review of Antimicrobial Resistance programs in Latin America and the Caribbean" awarded by Pfizer Inc. 2020 - 2021
- Fostering Antimicrobial Resistance Response (AMR) in Latin America and the Caribbean (LAC) 2018-2021 awarded by Pfizer Inc. 2018 - 2021
- Building the agenda to accelerate cervical cancer elimination A partnership call to action with the Pan-American Health Organization PAHO for Latin America and the Caribbean awarded by Merck & Co. Inc. MSD Phamaceuticals Priv 2020 - 2021
- Fostering Antimicrobial Resistance in Latin America and the Caribbean A Review of Antimicrobial Resistance programs in Latin America and the Caribbean awarded by Merck & Co. Inc. MSD Phamaceuticals Priv 2020 - 2021
- Review of National Immunization Calendars of the Expanded Program of Immunization (EPI) in Countries of Latin America and the Caribbean. Preliminary Observations on Financial and Funding Mechanisms of the National Immunization Programs awarded by Sanofi 2018 - 2021
- Assessment of the impact of the SARS-Cov-2 coronavirus pandemic (Covid-19) in National Immunization Programs in Latin America and the Caribbean awarded by GlaxoSmithKline GSK 2020 - 2021
- STATE OF THE ART PREVENTION AND CONTROL OF PERTUSSIS IN LATIN AMERICA AND THE CARIBBEAN awarded by Sanofi 2018 - 2020
- Assessment of acellular vaccination programs in Mexico, Costa Rica, and Panama awarded by Sanofi 2018 - 2020
- Develop Guidelines for Antimicrobial Stewardship For Latin America and Caribbean region awarded by Sanofi 2018 - 2019
- LATIN AMERICAN AND CARIBBEAN DIABETES NETWORK: A FRAMEWORK FOR ACTION awarded by Sanofi 2018 - 2019
- Review of National Immunization Calendar of the Expanded Program of Immunization (EPI) in countries of Latin America and the Caribbean. Preliminary Observations on Financial and Funding Mechanisms of the National Immunization Programs awarded by Fed Latinoamericana Indus Farmaceutica 2018 - 2019
- Public policy symposium awarded by Merck & Co. Inc. MSD Phamaceuticals Priv 2017 - 2019
- Global health conference and Global Health Consortium activities related to the focus of the Conference. awarded by Sanofi 2017 - 2019
- Sponsorship 8th International Conference awarded by Sanofi 2018
- Sponsorship 8th International Conference : building Alliances in Global Health awarded by Sanofi 2018
- Antimicrobial Stewardship for Latin America and the Caribbean Region awarded by Merck & Co. Inc. MSD Phamaceuticals Priv 2017 - 2018
- Sponsor GHC activities on key issues on global health and emerging diseases awarded by Oxitec Ltd 2017
- Geospatial Data and Outreach Facilitation Systems for Vaccination Analysis and Management awarded by Sanofi 2016 - 2017
- Workshop on Antimicrobial Resistance in Latin America and the Caribbean and Florida awarded by Merck & Co. Inc. MSD Phamaceuticals Priv 2016 - 2017
- Workshop on Health access and policies in Latin American and Caribbean Countries (LACC) awarded by Novartis Latin America Services Inc 2016
- DENGUE VACCINE GUIDELINES DEVELOPMENT awarded by Sanofi 2016
co-principal investigator on
Contact
full name
- Carlos Espinal Tejada
